Edition:
India

Teladoc Inc (TDOC.N)

TDOC.N on New York Stock Exchange

68.55USD
20 Jul 2018
Change (% chg)

$-1.85 (-2.63%)
Prev Close
$70.40
Open
$70.55
Day's High
$70.55
Day's Low
$68.35
Volume
206,055
Avg. Vol
167,387
52-wk High
$71.25
52-wk Low
$27.45

Summary

Name Age Since Current Position

David Snow

63 2014 Independent Chairman of the Board

Peter McClennen

48 2017 President

Jason Gorevic

46 2017 Chief Executive Officer, Director

Mark Hirschhorn

53 2016 Chief Financial Officer, Chief Operating Officer, Executive Vice President

Lewis Levy

59 2017 Chief Medical Officer

Adam Vandervoort

43 2015 Chief Legal Officer and Secretary

Helen Darling

76 2016 Independent Director

William Frist

66 2014 Independent Director

Michael Goldstein

76 2015 Independent Director

Brian McAndrews

59 2017 Independent Director

Thomas McKinley

66 2009 Independent Director

Arneek Multani

44 2008 Independent Director

Kenneth Paulus

58 2017 Independent Director

David Shedlarz

69 2016 Independent Director

Biographies

Name Description

David Snow

Mr. David B. Snow, Jr., is an Independent Chairman of the Board of the TELADOC, INC. since December 2014. He became a member of our Board in February 2014; he became chairman of our board in December 2014. Since February 2014, Mr. Snow has served as Chairman and Chief Executive officer of Cedar Gate Technologies, Inc., a provider of analytic and information technology services to doctor and hospital organizations entering risk-based reimbursement arrangements with insurers. Until April 2012, Mr. Snow was Chairman and Chief Executive Officer of Medco Health Solutions, Inc., a leading pharmacy benefit manager. His current board service includes CareCentrix (since 2014) and Pitney Bowes, Inc. (since 2006). He formerly served as a director of Medco Health Solutions, Inc. In addition to his experience as the chief executive officer of a public company, Mr. Snow has a strong background in operations, having served in leadership positions at several companies, including WellChoice (Empire Blue Cross Blue Shield) and Oxford Health Plans. Mr. Snow earned a B.S. in Economics from Bates College and a Master’s Degree in Health Care Administration from Duke University. Our Board has concluded that Mr. Snow should serve as a director because of his broad experience in the healthcare industry and his significant core business skills, including financial and strategic planning.

Peter McClennen

Mr. Peter A. McClennen is President of the TELADOC, INC. He has acted as president, Best Doctor’s Division, of the Company since July 2017. From 2015 until joining the Company in 2017, Mr. McClennen was chief executive officer of Best Doctors, Inc. (“Best Doctors”), where he oversaw the global expansion of Best Doctors’ product portfolio and eventual acquisition by the Company. From 2008 to 2015, Mr. McClennen acted as president of dbMotion, Inc., an innovative provider of medical informatics. He has also held senior leadership operations positions at healthcare companies Allscripts Health Solutions, GE Healthcare, Fujifilm Medical Systems and AMICAS Inc. Mr. McClennen holds a bachelor’s degree from the University of Rhode Island.

Jason Gorevic

Mr. Jason Gorevic is Chief Executive Officer, Director of the TELADOC, INC. He has acted as president, Best Doctor’s Division, of the Company since July 2017. From 2015 until joining the Company in 2017, Mr. McClennen was chief executive officer of Best Doctors, Inc. (“Best Doctors”), where he oversaw the global expansion of Best Doctors’ product portfolio and eventual acquisition by the Company. From 2008 to 2015, Mr. McClennen acted as president of dbMotion, Inc., an innovative provider of medical informatics. He has also held senior leadership operations positions at healthcare companies Allscripts Health Solutions, GE Healthcare, Fujifilm Medical Systems and AMICAS Inc. Mr. Gorevic earned a B.A. in international relations from the University of Pennsylvania. Our Board has concluded that Mr. Gorevic should serve as a director because of his leadership role with Teladoc and because of his broad experience in the healthcare industry.

Mark Hirschhorn

Mr. Mark J. Hirschhorn serves as Chief Financial Officer, Chief Operating Officer, Executive Vice President of the TELADOC, INC. Mr. Hirschhorn is an experienced senior financial and operations executive who has worked with numerous entrepreneurial ventures in a variety of different market segments. From April 2004 to October 2012, Mr. Hirschhorn served as Executive Vice President and Chief Financial Officer of RCS/Media Monitors, an international software technology company that serves the media and entertainment markets. From 2000 to 2003, Mr. Hirschhorn served as the Chief Financial Officer in a number of technology companies, including BT Radianz. From 1996 to 2000, he spent five years as the Vice President and Global Controller of RSL Communications, a publicly traded multinational telecommunications company, and as Chief Financial Officer of Deltathree Communications, a publicly traded RSL subsidiary and pioneer in VOIP technology. He started his professional career with Deloitte and spent nine years with the firm. Mr. Hirschhorn earned a B.A. from Rutgers University and an M.B.A. from Rutgers Business School. Mr. Hirschhorn is a CPA and a member of the American Institute of Certified Public Accountants.

Lewis Levy

Dr. Lewis Levy is a Chief Medical Officer of TELADOC, INC. in July 2017. Dr. Levy is responsible for leading the Company’s global medical affairs and quality initiatives, as well as overseeing the expansion of Teladoc’s physician network. Dr. Levy previously served as chief medical officer at Best Doctors, where he significantly contributed to the company’s medical standards and reputation for quality care in highly complex, specialized clinical cases. Dr. Levy has more than 25 years of clinical experience as an internist at Harvard Vanguard Medical Associates in Boston, and has had an extensive teaching career at Harvard Medical School and the Brigham and Women’s Hospital. Dr. Levy holds a B.S. from Cornell University, Phi Beta Kappa, and holds a medical degree from the University of Rochester School of Medicine and Dentistry. He completed his residency in Internal Medicine at the Graduate Hospital of the University of Pennsylvania.

Adam Vandervoort

Mr. Adam C. Vandervoort serves as Chief Legal Officer and Secretary of the TELADOC, INC. since February 2015. Mr. Vandervoort joined Teladoc in February 2015. For more than five years prior to that, he was Corporate Vice President, General Counsel and Secretary of Independence Holding Company, a publicly traded insurance holding company. Mr. Vandervoort is licensed to practice law in the states of California, Connecticut and New York. He holds a J.D. from the University of Pennsylvania Law School and A.M. and A.B. degrees from the University of Chicago.

Helen Darling

Ms. Helen Darling is an Independent Director of the TELADOC, INC. Ms. Darling is currently Strategic Advisor on Health Benefits and Health Care to the National Business Group on Health, a national nonprofit, membership organization devoted exclusively to providing practical solutions to its employer-members’ most important health care problems and representing larges employers’ perspectives on national health policy issues; from 2001 to May 1, 2014, she was President and CEO of this group. Ms. Darling is a board member and former Chair of the National Quality Forum, an independent, nonprofit organization that brings together leaders and experts to improve healthcare quality and safety through measurement; from January 2016 until February 2017, she was Interim President and CEO of this organization. Ms. Darling is a director of the Congressionally created Reagan-Udall Foundation, which supports the mission of the FDA. Ms. Darling participates on: the Committee on Performance Measurement of the National Committee for Quality Assurance (co-chair for 10 years); the Medical Advisory Panel, Center for Clinical Effectiveness, Blue Cross Blue Shield Association; Advisory Boards for the Peterson Foundation and GE’s healthymagination.

William Frist

Dr. William H. Frist, M.D.,is an Independent Director of the TELADOC, INC. since September 2014. Dr. Frist has served as a Partner in Cressey & Company, a private equity firm focused exclusively on investing in and building leading healthcare businesses. He is Chairman of the Cressey Distinguished Executive Council. As a U.S. Senator, Dr. Frist represented Tennessee for 12 years where he served on both the Finance and HELP committees responsible for writing all health legislation. He served as U.S. Senate Majority Leader from 2003 to 2006. Prior to the Senate, Dr. Frist spent 20 years in clinical medicine, completing surgical training at Harvard’s Massachusetts General Hospital and Stanford, and he subsequently founded the Vanderbilt Multi-Organ Transplant Center. Dr. Frist serves as an adjunct professor of Cardiac Surgery at Vanderbilt University and Clinical Professor of Surgery at Meharry Medical College. His previous board service includes Princeton University, the Smithsonian Institution and the Clinton Bush Haiti Fund. Dr. Frist currently serves as a director of the publicly held companies Select Medical and AECOM, and serves on AECOM’s audit committee. In addition, he serves on the boards of Unitek, Aegis, Aspire, MDSave, Cognosante and Accolade. He previously served as a director of URS Corporation from November 2009 to 2014, and on the board of Third National Bank from 1990 to 1994.

Michael Goldstein

Mr. Michael S. Goldstein, CPA is an Independent Director of the TELADOC, INC.since February 2015. Mr. Goldstein was employed by Ernst & Young (and its predecessor firms) from 1963 to 1979, including six years as an audit partner. Mr. Goldstein served as Chairman of Toys “R” Us, Inc. from 1998 to 2001, Chief Executive Officer from 1999 to 2000, Vice Chairman and Chief Executive Officer from 1994 to 1998 and Chief Financial Officer from 1983 to 1994. Mr. Goldstein has been a director of BioScrip, Inc. since 2015 and is chairman of the audit committee and a member of the governance, compliance and nominating committee and corporate strategy committee. Mr. Goldman was also a director and chairman of the audit committee of Pacific Sunwear of California, Inc. from 2004 to 2016. Mr. Goldstein is on the boards of two non- public companies: RiHappy, the largest Brazilian toy retailer; and Bank Leumi-USA. He is also a Global Senior Advisor of Jefferies, Inc. Mr. Goldstein is a board member and former Chairman of the Board of the 92nd Street Y and serves on the board of Rosie’s Theater Kids. He is Chairman of the Northside Center for Child Development. Mr. Goldstein served on the boards of the following public companies within the last five years: Charming Shoppes, Inc., from 2008 to 2012; 4 Kids Entertainment, Inc. from 2002 to 2012 and Medco Health Solutions, Inc. from 2005 to 2012.

Brian McAndrews

Mr. Brian P. McAndrews is an Independent Director of the TELADOC, INC. Mr. McAndrews currently sits on the board of Amplero, a recognized leader in leveraging artificial intelligence marketing to maximize customer lifetime value and loyalty, and is the former CEO, president, and chairman of Pandora Media, the internet radio company known for applying machine learning to song selection. During his more than 25 years in the technology and digital media markets, he also served as president and CEO of aQuantive, Inc., a top ten global digital marketing services and AdTech company that was an innovator in ad targeting and personalization, and was acquired by Microsoft. In addition to his experience in technology and AI, McAndrews has also spent a significant portion of his career driving growth and innovation for leading advertising and content companies. For nearly a decade he held positions of increasing responsibility at ABC, Inc., leaving as executive vice president and general manager of ABC Sports. He is on the board of The New York Times, chairing the Technology and Innovation Committee, and is chairman of the board of Grubhub. His consumer board experience includes working with Blue Nile, The Wine Group, and The United Way of King County.

Thomas McKinley

Mr. Thomas G. McKinley is an Independent Director of the TELADOC, INC. since November 2009. Mr. McKinley is a General Partner and the West Coast Representative for Cardinal Partners, a venture-capital firm focused exclusively on healthcare investing. Prior to joining Cardinal, Mr. McKinley was the co-founder and Co-Managing Partner of Partech International. Mr. McKinley has over 35 years of investment experience. Mr. McKinley currently serves on the board of directors of lifeIMAGE, a cloud-based medical imaging sharing platform for hospitals, physicians and patients. In addition, Mr. McKinley is the founding CEO and Director of Cardinal Analytx, a software start-up spun out of Stanford University that was created to identify and target high-cost patients for early medical interventions. Mr. McKinley earned an undergraduate degree in Economics from Harvard University, an M.S. in Accounting from New York University and an M.B.A. from the Stanford University Graduate School of Business. Our Board has concluded that Mr. McKinley should serve as a director because of his significant directorship experience and his broad experience in the healthcare and technology industries.

Arneek Multani

Mr. Arneek Multani is an Independent Director of the TELADOC, INC. since 2008. Mr. Multani is a Managing Director of Trident Capital, where he leads the firm’s Healthcare IT practice, and is a Co-Founder and Managing Director of TC Growth, a growth-equity firm spun out of Trident Capital in 2015. Prior to joining Trident in 2002, Mr. Multani was an Associate at McCown De Leeuw, a private equity firm specializing in leveraged buy-outs, where he focused on investing in the health and fitness industries. He started his career as an analyst at Morgan Stanley & Co in the Media & Telecommunications area of the Mergers & Acquisitions Group. Mr. Multani currently sits on the board of directors of Imagine Health, Arrohealth and HealthMEDX. His past directorships and observer-ships include Acclaris, Resolution Health and Profex. Mr. Multani earned a B.S. in Economics from Wharton School of Business and a B.A.S. in Systems Engineering from the Moore School of Engineering at the University of Pennsylvania. He earned his M.B.A. from the Stanford University Graduate School of Business. Our Board has concluded that Mr. Multani should serve as a director because of his broad experience in the healthcare industry and his significant core business skills, including financial and strategic planning.

Kenneth Paulus

Mr. Kenneth H. Paulus is an Independent Director of the TELADOC, INC. Mr. Paulus was President and CEO of Allina Health, one of the nation’s largest not-for-profit integrated delivery systems. Prior to his appointment as CEO, he served as president and Chief Operating Officer of Allina Health. Before joining Allina, Mr. Paulus was the President and CEO of Atrius Health System, one of the largest integrated physician organizations in New England and a teaching and research affiliate of Harvard Medical School. He also served as the Chief Operating Officer of Boston-based Partners Community Health Care, a teaching affiliate of Harvard Medical School that includes Massachusetts General Hospital and Brigham and Women’s Hospital. Mr. Paulus is an executive advisor at Water Street Healthcare Partners, a private investment firm, and currently serves on the boards of Healthgrades and Breg. Mr. Paulus received his Masters of Healthcare Administration and Management from the University of Minnesota, and a Bachelor of Arts in biology from Augustana College. Our Board has concluded that Mr. Paulus should serve as a director because of his background serving in leadership roles in the healthcare industry.

David Shedlarz

Mr. David L. Shedlarz is an Independent Director of the TELADOC, INC. He is the former vice chairman, executive vice president and chief financial officer of Pfizer, Inc., having had worldwide responsibility for the company’s former Medical Technology Group. During his 31-year tenure at Pfizer, Mr. Shedlarz played a key role in shaping the strategic direction that drove the company’s impressive growth and helped establish it as an industry leader and innovator. Among his senior leadership roles were that of executive vice president beginning in 1999, and then vice chairman in 2005, serving until his retirement in 2007. Mr. Shedlarz sits on the boards of The Hershey Company, Pitney Bowes Inc. and the Teacher Insurance and Annuity Association. He holds a Master of Business Administration in finance and accounting from New York University, Leonard N. Stern School of Business, and a Bachelor of Science in economics and mathematics from Oakland/Michigan State University. Our Board has concluded that Mr. Shedlarz should serve as a director because of his deep experience in public company finance, his experience as a director of large public companies and his prior service as the chief financial officer of one of the world’s leading pharmaceutical corporations.

Basic Compensation

Name Fiscal Year Total

David Snow

211,581

Peter McClennen

9,704,830

Jason Gorevic

7,104,440

Mark Hirschhorn

3,271,040

Lewis Levy

2,353,150

Adam Vandervoort

1,704,170

Helen Darling

175,817

William Frist

183,817

Michael Goldstein

188,051

Brian McAndrews

219,876

Thomas McKinley

180,817

Arneek Multani

181,812

Kenneth Paulus

257,147

David Shedlarz

194,290
As Of  31 Dec 2017